"Your health and safety are always our top priority. To help you protect yourself and your loved ones, we’ve gathered the most important information and guidance on the coronavirus and COVID-19. Go to our website. You have many ways to get care without leaving the comfort of your home - including an e-visit, phone, video appointments, and email. This allows you to still get great care while helping to address the community spread of COVID-19. If you’re concerned about your specific health condition, call 1-800-611-1811 (TTY 711) to talk to an advice nurse 24/7."

During the past decade, Kaiser Permanente-Glenlake Medical Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente-Glenlake Medical Center" #1 collaborator was "Canadian Cancer Trials Group" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente-Glenlake Medical Center" are "Breast Carcinoma" (1 trials) and "Node Positive HER2 Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Kaiser Permanente-Glenlake Medical Center" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente-Glenlake Medical Center" are "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin" (1 trials), "Health Education Program" (1 trials), "Placebo" (1 trials) and "Weight Loss Intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente-Glenlake Medical Center" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Kaiser Permanente-Glenlake Medical Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Kaiser Permanente-Glenlake Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente-Glenlake Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".